Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abzu is a Danish-Spanish deep tech company that specializes in artificial intelligence for the life sciences, particularly in the discovery and development of RNA-based therapeutics. The company's proprietary technology, the Q-lattice, is a symbolic AI platform that generates transparent and explainable models, allowing researchers to understand the underlying biological mechanisms of drug candidates. Abzu collaborates with pharmaceutical and biotech companies to optimize lead candidates, predict off-target effects, and accelerate the development of antisense oligonucleotides and siRNAs. By combining high-performance computing with advanced machine learning, Abzu aims to transform the drug discovery process from black-box predictions to actionable biological insights.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Christian Westergaard.